Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Gallium-68-DOTA-N-Octreotide1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
2Octreotide1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 67, 75, 84, 85, 89, 193, 227
3Octreotide a azione pronta 0,1 mg1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227
4OCTREOTIDE ACETATE2件: Acetate,
Octreotide		1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227
5OCTREOTIDE ACETATO1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227
6Octreotide LAR1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 227
7Octreotide LAR / Sandostatin LAR (LAR=long acting release)1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84
8Octreotide-LAR1件: Octreotide1件: D00442 (Name: Octreotide)1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 67